Hot Keywords
rare disease orphan drug


Volume 1, Issue 3 (2022) –

Cover Picture: In late 2021, the health technology assessment of the French National Authority for Health was seized by the French Ministry of Solidarity and Health to address a specific challenge, the identification of solutions contributing to the development of the methodological expertise in new types of clinical studies for rare diseases. Experts from the rare diseases environment were gathered by OrphanDev, the French network of expertise dedicated to rare diseases. They allowed to identify some of the current issues in France concerning rare diseases, and then present different solutions, in particular related to the evaluation process of orphan drugs and the collection of data on rare diseases.
view this paper

Conference Report


Technical Note

Case Report

Actions for selected articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties